Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1060736/000119312522150770/d322851d8k.htm
May 2022
May 2022
May 2022
April 2022
April 2022
April 2022
March 2022
February 2022
Please wait while we load the requested 8-K report or click the link below:
https://last10k.com/sec-filings/report/1060736/000119312522150770/d322851d8k.htm
Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Seattle Genetics Inc Wa.
Seattle Genetics Inc Wa's Definitive Proxy Statement (Form DEF 14A) filed after their 2022 10-K Annual Report includes:
Financial Statements, Disclosures and Schedules
Inside this 8-K Corporate News
Material Contracts, Statements, Certifications & more
Seattle Genetics Inc Wa provided additional information to their SEC Filing as exhibits
Ticker: SGENEvents:
CIK: 1060736
Form Type: 8-K Corporate News
Accession Number: 0001193125-22-150770
Submitted to the SEC: Mon May 16 2022 6:10:07 AM EST
Accepted by the SEC: Mon May 16 2022
Period: Sunday, May 15, 2022
Industry: Biological Products No Disgnostic Substances